Related Experiment Video
Updated: Jan 22, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
Published on: July 14, 2021
The microRNA in ventricular remodeling: the miR-30 family
Xiaonan Zhang1, Shaoyang Dong2, Qiujin Jia1
1Department of Cardiovascular Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
Insights
MicroRNA-30 (miR-30) plays a key role in ventricular remodeling (VR) by influencing processes like apoptosis and fibrosis. Understanding miR-30 mechanisms is crucial for treating cardiovascular diseases (CVDs).
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Biomedical Research
Background:
- Ventricular remodeling (VR) involves cardiomyocyte apoptosis, hypertrophy, and fibrosis, driven by cardiovascular diseases (CVDs) like hypertension and heart failure (HF).
- VR is an independent risk factor for CVDs, leading to impaired heart function, increased cardiovascular events, and mortality.
- MicroRNAs (miRNAs) regulate gene expression post-transcriptionally and are implicated in various CVDs.
Purpose of the Study:
- To review the mechanisms by which the microRNA-30 (miR-30) family influences ventricular remodeling (VR).
- To explore the role of miR-30 in VR across diverse conditions including ischemic heart disease (IHD), hypertensive heart disease (HHD), diabetic cardiomyopathy (DCM), and cardiotoxicity (CTX).
Main Methods:
- Literature review of studies investigating miR-30 and VR.
- Analysis of molecular mechanisms including autophagy, apoptosis, oxidative stress, and inflammation.
- Synthesis of findings related to miR-30's involvement in various disease-induced VR models.
Main Results:
- The miR-30 family is abundant in the heart and significantly impacts VR.
- miR-30 regulates key pathological processes in VR, such as autophagy, apoptosis, oxidative stress, and inflammation.
- Dysregulation of miR-30 is associated with VR in multiple CVD contexts.
Conclusions:
- The miR-30 family is a critical regulator of ventricular remodeling.
- Targeting miR-30 pathways offers potential therapeutic strategies for managing VR in various cardiovascular diseases.
- Further research into miR-30's specific roles can advance treatments for heart conditions.
Abstract:
Ventricular remodeling (VR) is a complex pathological process of cardiomyocyte apoptosis, cardiac hypertrophy, and myocardial fibrosis, which is often caused by various cardiovascular diseases (CVDs) such as hypertension, acute myocardial infarction, heart failure (HF), etc. It is also an independent risk factor for a variety of CVDs, which will eventually to damage the heart function, promote cardiovascular events, and lead to an increase in mortality. MicroRNAs (miRNAs) can participate in a variety of CVDs through post-transcriptional regulation of target gene proteins. Among them, microRNA-30 (miR-30) is one of the most abundant miRNAs in the heart. In recent years, the study found that the miR-30 family can participate in VR through a variety of mechanisms, including autophagy, apoptosis, oxidative stress, and inflammation. VR is commonly found in ischemic heart disease (IHD), hypertensive heart disease (HHD), diabetic cardiomyopathy (DCM), antineoplastic drug cardiotoxicity (CTX), and other CVDs. Therefore, we will review the relevant mechanisms of the miR-30 in VR induced by various diseases.
Related Concept Videos
Protein Families
Protein Families
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Families
MicroRNAs
MicroRNAs

